Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: SEroma Reduction pOst MAstectomy "SEROMA Study" [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating seroma reduction after mastectomy (SEROMA Study) with unclear current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Seroma Complicating A Procedure, Hematoma Postoperative | Phase 4 | Status: UNKNOWN